相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma
Hamid Nikbakht et al.
NATURE COMMUNICATIONS (2016)
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics
Lindsey M. Hoffman et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
David Castel et al.
ACTA NEUROPATHOLOGICA (2015)
Advances in the development of histone lysine demethylase inhibitors
Tamara Maes et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Catherine S. Grasso et al.
NATURE MEDICINE (2015)
11C-methinine uptake correlates with MGMT promoter methylation in nonenhancing gliomas
Yoshiko Okita et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2014)
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
Panagiotis Ntziachristos et al.
NATURE (2014)
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Rintaro Hashizume et al.
NATURE MEDICINE (2014)
H3F3A K27M mutations in thalamic gliomas from young adult patients
Koki Aihara et al.
NEURO-ONCOLOGY (2014)
The Role of Probabilistic Tractography in the Surgical Treatment of Thalamic Gliomas
David Kis et al.
OPERATIVE NEUROSURGERY (2014)
Diagnostic Challenges of Primary Thalamic Gliomas-Identification of a Minimally Enhancing Neuroradiological Subtype with Aggressive Neuropathology and Poor Clinical Outcome
K. M. Kurian et al.
CLINICAL NEURORADIOLOGY (2014)
H3F3A K27M Mutation in Pediatric CNS Tumors A Marker for Diffuse High-Grade Astrocytomas
Gerrit H. Gielen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Sebastian Bender et al.
CANCER CELL (2013)
Surgical management of thalamic gliomas: case selection, technical considerations, and review of literature
Narayanam Anantha Sai Kiran et al.
NEUROSURGICAL REVIEW (2013)
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Peter W. Lewis et al.
SCIENCE (2013)
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Dominik Sturm et al.
CANCER CELL (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Thalamic high-grade gliomas in children: a distinct clinical subset?
Christof M. Kramm et al.
NEURO-ONCOLOGY (2011)
Surgical resection of thalamic tumors in children: approaches and clinical results
Marc Baroncini et al.
CHILDS NERVOUS SYSTEM (2007)
Thalamic tumors in children: a reappraisal
Stephanie Puget et al.
JOURNAL OF NEUROSURGERY (2007)
Thalamic gliomas in children: an extensive clinical, neuroradiological and pathological study of 14 cases
Carla Fernandez et al.
CHILDS NERVOUS SYSTEM (2006)
Feasibility and advisability of resections of thalamic tumors in pediatric patients
AL Albright
JOURNAL OF NEUROSURGERY (2004)
Chemotherapy: Low-grade gliomas of the hypothalamus and thalamus
RJ Packer
PEDIATRIC NEUROSURGERY (2000)
分享论文
